Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - haloxyfop-p present as the haloxyfop-p-methyl - emulsifiable concentrate - haloxyfop-p present as the haloxyfop-p-methyl phenoxy acids-propionics active 900.0 g/l - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fmc australasia pty ltd - chlorantraniliprole - water dispersible granule - chlorantraniliprole benzene active 350.0 g/kg - insecticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agbitech pty ltd - nuclear polyhedrosis virus of helicoverpa armigera - soluble concentrate - nuclear polyhedrosis virus of helicoverpa armigera biological-virus active 0.0 ml - insecticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - haloxyfop present as haloxyfop-p methyl ester - emulsifiable concentrate - haloxyfop present as haloxyfop-p methyl ester phenoxy acids-ester active 900.0 g/l - herbicide

United States - English - NLM (National Library of Medicine)

amryt pharmaceuticals dac - metreleptin (unii: tl60c27rlh) (metreleptin - unii:tl60c27rlh) - metreleptin 11.3 mg in 2.2 ml - myalept (metreleptin) for injection is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. limitations of use - the safety and effectiveness of myalept for the treatment of complications of partial lipodystrophy have not been established. - the safety and effectiveness of myalept for the treatment of liver disease, including nonalcoholic steatohepatitis (nash), have not been established. - myalept is not indicated for use in patients with hiv-related lipodystrophy. - myalept is not indicated for use in patients with metabolic disease, including diabetes mellitus and hypertriglyceridemia, without concurrent evidence of congenital or acquired generalized lipodystrophy. myalept is contraindicated in patients with general obesity not associated with congenital leptin deficiency. myalept has not been shown to be effective in treating general obesity, and the development of anti-metreleptin antibodi

United States - English - NLM (National Library of Medicine)

nash finch -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oz crop pty ltd - s-indoxacarb - water dispersible granule - s-indoxacarb active active 312.5 g/kg - insecticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fmc australasia pty ltd - chlorantraniliprole - water dispersible granule - chlorantraniliprole benzene active 700.0 g/kg - insecticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - nuclear polyhedrosis virus of helicoverpa armigera - soluble concentrate - nuclear polyhedrosis virus of helicoverpa armigera biological-virus active 10000.0 mobs/ml - insecticide

Kenya - English - Pharmacy and Poisons Board

blue cross laboratories ltd a-12 midc ambad nashik maharashtra 422 010 india - cefixime dispersible - dispersible tablet - 100 mg / tablet - beta-lactamantibacterials: third-generation